Committee for Orphan Medicinal Products (COMP): 16-18 January 2024
Date:
16/01/2024 to 18/01/2024
Location:
European Medicines Agency, Amsterdam, the Netherlands
The Committee for Orphan Medicinal Products (COMP) is the committee that is responsible for reviewing applications for 'orphan medicinal product designation' for medicines intended for the diagnosis, prevention or treatment of rare diseases.